Publications by authors named "Dev Datta"

Claim this Profile
S
Standardising lipid testing and reporting in the United Kingdom; a joint statement by HEART UK and The Association for Laboratory Medicine.
Julia S Kenkre, Tina Mazaheri, R Dermot G Neely, Handrean Soran, Dev Datta

Ann Clin Biochem· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare variant genetic landscape of familial chylomicronemia syndrome (FCS) in the United Kingdom.
Bilal Bashir, Natalie Forrester, Paul Downie, Sarah Marsh, Carolyn Dent, Dev Datta

Genet Med Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethnic Diversity and Distinctive Features of Familial Versus Multifactorial Chylomicronemia Syndrome: Insights From the UK FCS National Registry.
Bilal Bashir, Paul Downie, Natalie Forrester, Anthony S Wierzbicki, Charlotte Dawson, Dev Datta

Arterioscler Thromb Vasc Biol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS).
Bilal Bashir, See Kwok, Anthony S Wierzbicki, Alan Jones, Charlotte Dawson, Dev Datta

Atherosclerosis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of clinical lipidology in the UK.
Jaimini Cegla, Dev Datta, Alan Rees, Handrean Soran, Gilbert Thompson

Clin Med (Lond)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing from lipoprotein apheresis to evolocumab treatment lowers circulating levels of arachidonic acid and oxylipins.
Chaoxuan Wang, Anne Kaufmann, Nadja Kampschulte, Ulf Elbelt, Ursula Kassner, Dev Datta

Atheroscler Plus· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis.
Nadeem Qureshi, Bethan Woods, Rita Neves de Faria, Pedro Saramago Goncalves, Edward Cox, Dev Datta

Health Technol Assess· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic Options.
Bilal Bashir, Jan H Ho, Paul Downie, Paul Hamilton, Gordon Ferns, Dev Datta

Metabolites· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute effect of a single session of lipoprotein apheresis on central haemodynamics in patients with familial hypercholesterolaemia.
Elizabeth A Ellins, Suzanne Watkins, D Aled Rees, Dev B N Datta, Julian P Halcox

Atherosclerosis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK.
Zohaib Iqbal, Jan Hoong Ho, Safwaan Adam, Michael France, Akheel Syed, Dev Datta

Atherosclerosis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of evolocumab on lipoprotein apheresis requirement and lipid levels: Results of the randomized, controlled, open-label DE LAVAL study.
Seth J Baum, Tiziana Sampietro, Dev Datta, Patrick M Moriarty, Beat Knusel

J Clin Lipidol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "HEART UK consensus statement on Lipoprotein(a): A call to action" [Atherosclerosis 291 (2019) 62-70].
Jaimini Cegla, R Dermot G Neely, Michael France, Gordon Ferns, Chris D Byrne, Dev Datta

Atherosclerosis· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017" [Atherosclerosis 290 (November 2019) 44-51].
Alison Pottle, Gilbert Thompson, Mahmoud Barbir, Graham Bayly, Jaimini Cegla, Dev Borunendra Nath Datta

Atherosclerosis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HEART UK consensus statement on Lipoprotein(a): A call to action.
Jaimini Cegla, R Dermot G Neely, Michael France, Gordon Ferns, Chris D Byrne, Dev Datta

Atherosclerosis· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom.
Michael France, Alan Rees, Dev Datta, Gilbert Thompson, Nigel Capps

Atherosclerosis· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a new method for non-invasive assessment of vasomotor function.
Elizabeth A Ellins, Karl J New, Dev B N Datta, Suzanne Watkins, Kate Haralambos

Eur J Prev Cardiol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complications from micronutrient deficiency following bariatric surgery.
Helen O Wilson, Dev Bn Datta

Ann Clin Biochem· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipoprotein-apheresis reduces circulating microparticles in individuals with familial hypercholesterolemia.
Katherine D Connolly, Gareth R Willis, Dev B N Datta, Elizabeth A Ellins, Kristin Ladell

J Lipid Res· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis